NCT05143450

Brief Summary

Manual pressure is an effective, easy-to-apply, no preparation, and cost-effective method of reducing pain associated with the injection. This study will be carried out to determine the effect of manual pressure applied to the injection site on the pain level and crying time of the infants before the injection of the Diphtheria-Tetanus-Acellular Pertussis Vaccine (DTaP), Inactivated Polio Vaccine (IPV), and Haemophilus Influenzae Type b Vaccine (Hib) (5-in-1) in 2-month-old infants. The study will be conducted with the randomized controlled experimental method. Before the procedure, manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants in the experimental group. No non-pharmacological method will be used before vaccination to the infants in the control group. Pain scores of infants in the intervention and control groups will be evaluated before, during, and after vaccination. In addition, the total crying times of the babies will be calculated and recorded with a stopwatch.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

December 15, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2022

Completed
Last Updated

June 15, 2022

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

November 17, 2021

Last Update Submit

June 14, 2022

Conditions

Keywords

injectionmanual pressurepainpain managementvaccination

Outcome Measures

Primary Outcomes (1)

  • Change of Pain

    Pain will assess by the healthcare provider who performs the venipuncture procedure with the FLACC (Face, Legs, Activity, Cry, Consolability) Scale. This scale was developed to evaluate the pain of children aged 2 months to 7 years. The child's facial expression, leg movements, activity, crying, and comfortability behaviors are evaluated in relation to pain. These five behaviors are rated with 0, 1, or 2 points. The total score of the scale ranges from 0 to 10, and a high score indicates that the child has more pain. '0' points from the scale indicate no pain, '1-3' points indicate mild pain, '4-6' points indicate moderate pain, and '7-10' points indicate severe pain.

    Before vaccine injection, when the vaccine starts to be injected and immediately after the injector was removed.

Secondary Outcomes (1)

  • Crying time

    During vaccine injection and immediately after injection

Study Arms (2)

Experimental Group

EXPERIMENTAL

Before the procedure, manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants by the researcher.

Other: Manual Pressure

Control Group

NO INTERVENTION

No intervention will perform to reduce pain in the control group.

Interventions

In the experimental group manual pressure will be applied to the injection site with the thumb for 10 seconds to the infants by the researcher before the procedure. Manual pressure reduces pain within the framework of the gate control theory. According to the gate control theory, when pressure is applied to an area, a fiber transmits the feeling of pressure instead of pain and ultimately the pain sensation is alleviated.

Experimental Group

Eligibility Criteria

Age4 Months - 4 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Being a healthy baby born at term
  • Being 4 months old
  • Having no chronic disease,
  • Having no neurological disease.
  • Not taking an analgesic drug within 24 hours before vaccination.

You may not qualify if:

  • Being an unhealthy baby born at preterm or post-term,
  • Being younger or older than 4 months old,
  • Having a chronic disease,
  • Having a neurological disease,
  • Taking an analgesic drug within 24 hours before vaccination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kumkapi Family Health Center

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaPain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, PhD

Study Record Dates

First Submitted

November 17, 2021

First Posted

December 3, 2021

Study Start

December 15, 2021

Primary Completion

June 2, 2022

Study Completion

June 2, 2022

Last Updated

June 15, 2022

Record last verified: 2021-11

Locations